November 13-14, 2018
Apella by Alexandria Center,
The meeting place of peers and industry leaders in the NY/NJ biopharm community
This invitation-only, off-the-record forum brings together senior-level life sciences executives to network and share insights into the industry's challenges and opportunities.
What's New: Feed your vision
NY/NY CEO provides networking chemistry at its finest. You can hear the deals being hatched. Join your senior level community in shaping the future of biotech.
Key Note with Alex Denner on Board Governance
Join a keynote discussion on Board Governance with Alex Denner, Hedge Fund Operator and CIO of Sarissa Capital Management, arguably one of the biggest influencers in biopharma today.
War Stories with Jeremy Levin
Listen to war stories from true industry veteran Jeremy Levin, CEO, Ovid Therapeutics
Capital Investment, Partnerships, Market Outlooks
Keep your finger on the pulse of what is happening nationally in capital investment, partnerships, market outlooks and the state of the industry, plus how that plays out at the local level.
New York Investment Opportunities & Funding Initiatives
Sit in on a VC panel to hear what makes New York a unique opportunity for investment and biotech building.
Get an update on how funding initiatives are overcoming the challenges in real estate and talent for biotech development in New York.
A Focus on Innovative LS Tech Companies
Experience a spotlight session on Innovative Tech Life Science companies and feed your visionary ideas.
The Ultimate Pharma R&D Annual Review 2018
Access the ultimate report to tune into expert insights and score illuminating data on the trends that affected pharmaceutical R&D.
This is a trusted and highly-anticipated review of trends in drug development.
“It reflects what's really happening in the industry today and will probably confirm and confound some of your own beliefs on what's hot and what's not.”Author, Ian Lloyd, Senior Director of Pharma project and Data Integration
2018 Steering Committee
Meet the NY/NJ CEO Steering Committee, a distinguished group of industry thought leaders whose insights have helped shape our program into one that brings the most relevant players in the biopharma space to the table.